RNA-binding proteins in hematopoiesis and hematological malignancy.
American Society of Hematology
MetadataShow full item record
Hodson, D., Screen, M., & Turner, M. (2019). RNA-binding proteins in hematopoiesis and hematological malignancy.. Blood, 133 (22), 2365-2373. https://doi.org/10.1182/blood-2018-10-839985
RNA binding proteins (RBPs) regulate fundamental processes such as differentiation and self-renewal by enabling the dynamic control of protein abundance or isoforms, or through the regulation of non-coding RNA. RBPs are increasingly appreciated as being essential for normal hematopoiesis and they are understood to play fundamental roles in hematological malignancies by acting as oncogenes or tumor suppressors. Alternative splicing has been shown to play roles in the development of specific hematopoietic lineages and sequence specific mutations in RBPs lead to dysregulated splicing in myeloid and lymphoid leukemias. RBPs that regulate translation contribute to the development and function of hematological lineages, act as nodes for the action of multiple signaling pathways and contribute to hematological malignancies. These insights broaden our mechanistic understanding of the molecular regulation of hematopoiesis and offer opportunities to develop disease biomarkers and new therapeutic modalities.
Animals, Humans, Hematologic Neoplasms, RNA-Binding Proteins, Neoplasm Proteins, RNA, Neoplasm, RNA, Untranslated, Hematopoiesis, Mutation
We thank the Medical Research Council, The Biotechnology and Biological Sciences Research Council BBS/E/B/000C0428, Bloodwise, Cancer Research Therapeutics and Wellcome for funding research in the author’s laboratories.
Medical Research Council (MR/M008584/1)
External DOI: https://doi.org/10.1182/blood-2018-10-839985
This record's URL: https://www.repository.cam.ac.uk/handle/1810/291807
All rights reserved